Barbora Konečná1, Paulína Chobodová1, Jakub Janko1, Lenka Baňasová2, Janka Bábíčková1,3, Peter Celec1,4,5, Ľubomíra Tóthová1. 1. Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, 811 08 Bratislava, Slovakia. 2. Department of Stomatology and Maxillofacial Surgery, Comenius University, 812 50 Bratislava, Slovakia. 3. Department of Clinical Medicine, University of Bergen, 5021 Bergen, Norway. 4. Department of Molecular Biology, Faculty of Natural Sciences, Comenius University, 841 04 Bratislava, Slovakia. 5. Institute of Pathophysiology, Faculty of Medicine, Comenius University, 811 08 Bratislava, Slovakia.
Abstract
BACKGROUND: Periodontitis is a chronic disease with a complex etiology that includes bacterial colonization, excessive inflammation, and oxidative stress. The hormone melatonin has antioxidant properties and might contribute to alleviating chronic conditions by reducing oxidative stress. The aim of this study was to analyze the effect of exogenous melatonin on periodontitis in an animal model of the disease as well as in patients with periodontitis. METHODS: In rats with ligature-induced periodontitis, melatonin was administered in drinking water for two weeks. In the human study, patients with treatment-resistant periodontitis were asked to rinse their mouths with a solution containing melatonin or placebo every evening for two weeks. Periodontal status as well as salivary markers of oxidative stress were assessed at the end of the study. RESULTS: Neither radiography nor μCT revealed any significant effects of melatonin on alveolar bone loss. Gum recession was the only improved macroscopic measure in rats (p < 0.05). Analysis of salivary markers of oxidative stress revealed no effects of treatment in rats or humans despite clearly elevated melatonin concentrations in melatonin treated groups. CONCLUSION: Our results do not support the use of melatonin for the treatment of periodontitis. However, the negative outcome is limited by the short duration of the study and the chosen route of application as well as the dose of melatonin.
RCT Entities:
BACKGROUND:Periodontitis is a chronic disease with a complex etiology that includes bacterial colonization, excessive inflammation, and oxidative stress. The hormone melatonin has antioxidant properties and might contribute to alleviating chronic conditions by reducing oxidative stress. The aim of this study was to analyze the effect of exogenous melatonin on periodontitis in an animal model of the disease as well as in patients with periodontitis. METHODS: In rats with ligature-induced periodontitis, melatonin was administered in drinking water for two weeks. In the human study, patients with treatment-resistant periodontitis were asked to rinse their mouths with a solution containing melatonin or placebo every evening for two weeks. Periodontal status as well as salivary markers of oxidative stress were assessed at the end of the study. RESULTS: Neither radiography nor μCT revealed any significant effects of melatonin on alveolar bone loss. Gum recession was the only improved macroscopic measure in rats (p < 0.05). Analysis of salivary markers of oxidative stress revealed no effects of treatment in rats or humans despite clearly elevated melatonin concentrations in melatonin treated groups. CONCLUSION: Our results do not support the use of melatonin for the treatment of periodontitis. However, the negative outcome is limited by the short duration of the study and the chosen route of application as well as the dose of melatonin.
Authors: Nalaka S Gooneratne; Alena Y Z Edwards; Chen Zhou; Norma Cuellar; Michael A Grandner; Jeffrey S Barrett Journal: J Pineal Res Date: 2012-02-21 Impact factor: 13.007
Authors: Giovanni Matarese; Gaetano Isola; Giuseppe Pio Anastasi; Angelo Favaloro; Demetrio Milardi; Giovanna Vermiglio; Giuseppe Vita; Giancarlo Cordasco; Giuseppina Cutroneo Journal: Int J Mol Med Date: 2012-06-11 Impact factor: 4.101
Authors: G Gómez-Moreno; A Cutando-Soriano; C Arana; P Galindo; J Bolaños; D Acuña-Castroviejo; H-L Wang Journal: J Periodontal Res Date: 2007-12 Impact factor: 4.419
Authors: Danica C Slavish; Jennifer E Graham-Engeland; Joshua M Smyth; Christopher G Engeland Journal: Brain Behav Immun Date: 2014-09-07 Impact factor: 7.217